Table 2.

Associations between categorical PRSs and MM risk in 1813 patients and 8871 controls of AA

PRS categoryEuropean-weighted PRS*AA-weighted PRS1AA-weighted PRS2
OR (95% CI)PPHetOR (95% CI)PPHetOR (95% CI)PPHet
0%-10% 0.70 (0.57-0.86) 6.52 × 10−4 .94 0.52 (0.41-0.65) 1.49 × 10−8 .90 0.48 (0.37-0.60) 9.68 × 10−10 .56 
10%-25% 0.78 (0.66-0.92) 3.10 × 10−3 .30 0.70 (0.59-0.84) 7.16 × 10−5 .01 0.72 (0.60-0.85) 1.34 × 10−4 .83 
25%-75% (reference) NA NA NA NA NA NA 
75%-90% 1.24 (1.07-1.43) 3.71 × 10−3 .78 1.36 (1.18-1.56) 1.54 × 10−5 .99 1.39 (1.21-1.60) 2.76 × 10−6 .80 
90%-100% 1.61 (1.38-1.88) 1.41 × 10−9 .31 1.66 (1.43-1.94) 7.54 × 10−11 .37 1.82 (1.56-2.11) 9.43 × 10−15 .65 
PRS categoryEuropean-weighted PRS*AA-weighted PRS1AA-weighted PRS2
OR (95% CI)PPHetOR (95% CI)PPHetOR (95% CI)PPHet
0%-10% 0.70 (0.57-0.86) 6.52 × 10−4 .94 0.52 (0.41-0.65) 1.49 × 10−8 .90 0.48 (0.37-0.60) 9.68 × 10−10 .56 
10%-25% 0.78 (0.66-0.92) 3.10 × 10−3 .30 0.70 (0.59-0.84) 7.16 × 10−5 .01 0.72 (0.60-0.85) 1.34 × 10−4 .83 
25%-75% (reference) NA NA NA NA NA NA 
75%-90% 1.24 (1.07-1.43) 3.71 × 10−3 .78 1.36 (1.18-1.56) 1.54 × 10−5 .99 1.39 (1.21-1.60) 2.76 × 10−6 .80 
90%-100% 1.61 (1.38-1.88) 1.41 × 10−9 .31 1.66 (1.43-1.94) 7.54 × 10−11 .37 1.82 (1.56-2.11) 9.43 × 10−15 .65 

ORs were adjusted for age, sex, and PCs 1-10, P values are Wald P values, and PHet are P values of heterogeneity in fixed-effect meta analyses.

NA, not applicable.

*

European-weighted PRSs were constructed using the known 22 index SNPs reported in EUR GWASs, and weights were from original EUR GWASs.

AA-weighted PRS1 were constructed using the known 22 index SNPs reported in EUR GWASs, and weights were from AA MM.

AA-weighted PRS2 were constructed using 14 index SNPs (weights from AA MM) and 8 better AA markers (weights from AA MM and adjusted for their “winner’s curse” using a Bayesian approach).

Close Modal

or Create an Account

Close Modal
Close Modal